Daily Archives: Agosto 19, 2021 | LinksMedicus Free Medical News & Perspectives

Estudo do NIH mostra que não há nenhum benefício significativo do plasma convalescente para pacientes ambulatoriais de COVID-19 com sintomas iniciais.

19 Ago, 2021 | 12:29h

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms – NIH News Releases

Estudo original: Early Convalescent Plasma for High-Risk Outpatients with Covid-19 – New England Journal of Medicine

Comentário no Twitter

Convalescent plasma did not prevent disease progression in patients seen in EDs within 7 days after the onset #COVID19 symptoms. https://t.co/9gmIK3ntKH #IDTwitter pic.twitter.com/sirzn1uGL0

— NEJM (@NEJM) August 18, 2021

Estudos: proteção da vacina diminui com o tempo em relação à infecção por COVID, mas a proteção contra hospitalização é duradoura.

19 Ago, 2021 | 12:27h

Studies: COVID vaccine protection waning against infection but not hospitalization – CIDRAP

Estudo 1: Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 – CDC Morbidity and Mortality Weekly Report

Estudo 2: Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021 – CDC Morbidity and Mortality Weekly Report

Estudo 3: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 – CDC Morbidity and Mortality Weekly Report

Comentário no Twitter (fio – clique para saber mais)

Very excited to share our most recent publication about #CovidVaccine effectiveness, just published today by the IVY network. Especially relevant in light of today’s news about #boosters (spoiler – I’m skeptical about the need for boosters for all). 🧵https://t.co/GbAxgzpo7R

— Nida Qadir, MD (@NidaQadirMD) August 18, 2021

Ponto de vista | Combatendo a variante Delta do SARS-CoV-2.

19 Ago, 2021 | 12:25h

Confronting the Delta Variant of SARS-CoV-2, Summer 2021 – JAMA

Resposta do IDSA ao plano para doses suplementares de vacina para indivíduos já vacinados.

19 Ago, 2021 | 12:23h

Response to Plan for Supplemental Vaccine Doses for Vaccinated Individuals – Infectious Diseases Society of America

Decisão oficial dos EUA sobre doses de reforço da vacina contra Covid-19 confunde – e irrita – alguns cientistas.

19 Ago, 2021 | 12:22h

U.S. officials’ decision on Covid-19 booster shots baffles — and upsets — some scientists – STAT

Comentário no Twitter

Scientists I spoke to today had a lot of questions about the administration's decision to start giving Americans 3rd doses of the mRNA vaccines next month. “I’m not sure we had enough [data] to pull the trigger right now," one said. https://t.co/eHUndOrQL4

— Helen Branswell (@HelenBranswell) August 18, 2021

Estocagem de vacinas pelos países pode levar ao aumento dos casos de COVID-19 e ao surgimento de novas variantes.

19 Ago, 2021 | 12:20h

Vaccine nationalism and the dynamics and control of SARS-CoV-2 – Science

Comentário: Vaccine stockpiling by nations could lead to increase in COVID-19 cases, novel variant emergence – Princeton University

Comentário no Twitter

Published at @sciencemagazine, a new @PrincetonEnviro study shows that stockpiling driven by vaccine 'nationalism' could increase #COVID19 cases and the potential emergence of novel variants, stressing the importance of rapid global vaccine equity. https://t.co/ziN5fX0u2X

— Princeton University (@Princeton) August 18, 2021